Functional Electrical Stimulation for Facial Muscles

March 18, 2024 updated by: University Health Network, Toronto

Applying Functional Electrical Stimulation to Facial Muscles After Acute Paralysis

Partial or complete facial paralysis is the weakness of muscles of facial expression. Facial paralysis causes physical, social and emotional problems. Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated, causing them to contract This study is designed to help patients with facial nerve weakness.

Study Overview

Status

Terminated

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G 2C4
        • University Health Network

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients experiencing unilateral facial nerve paralysis Brackmann 5/6 or 6/6.

Exclusion Criteria:

  • History of epilepsy or seizures.
  • Individuals with metal orthopedic implants in the mouth (e.g. plates or screws).
  • Individuals suffering from fibromyalgia.
  • Individuals currently receiving any form of transcranial brain stimulation (e.g. rTMS, ECT, or MST).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acute Facial Nerve Injury with Intact Facial Nerve

40 sessions of FES (in a 14 week period)

Assessments will be taken during the beginning, middle, and end of each study arm.

Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated.
Experimental: Facial Nerve Grafting After Surgical Excision

40 sessions of FES (in a 14 week period)

Assessments will be taken during the beginning, middle, and end of each study arm.

Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated.
No Intervention: Standard of Care Group

No FES

Assessments will be taken at the same intervals as the interventions group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Lagophthalmos Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
Change in ability to close eyelids, measured in mm
Measured at week 0, 7 and 14
Change in Elevation of Corner of Mouth Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
Change in ability to raise corner of mouth, measured in mm
Measured at week 0, 7 and 14
Change House-Brackmann Scale Measurement Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
The House-Brackmann facial nerve grading scale is a measure of facial nerve impairment. The scale ranges from values 1 to 6, with larger values indicating greater facial nerve impairment.
Measured at week 0, 7 and 14
FaCE Questionnaire
Time Frame: Administered at week 0, 7 and 14
Patient-based instrument to measure both facial impairment and disability. This will be used to identify patient's perceived change in facial impairment for the duration of the study period.
Administered at week 0, 7 and 14
Change in Facial Movements Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
A video will be taken of the patient undergoing standard facial movements
Measured at week 0, 7 and 14
Study Interview
Time Frame: Administered at week 0, 7 and 14
A structured interview questionnaire administered by a study team member to identify any changes to the therapy that may be needed before further studies are conducted
Administered at week 0, 7 and 14

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Douglas Chepeha, MD, University Health Network, Toronto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Actual)

March 16, 2023

Study Completion (Actual)

March 16, 2023

Study Registration Dates

First Submitted

June 8, 2020

First Submitted That Met QC Criteria

June 30, 2020

First Posted (Actual)

July 7, 2020

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 18, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Facial Nerve Paresis

Clinical Trials on Application of FES to the Face

3
Subscribe